Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

I-Tech AB recognized with European Marine Biocides Technology Innovation Award for Selektope® antifouling ingredient

I-Tech AB has been recognized as the technology innovation leader in the European marine biocides market, resulting in the company receiving the 2017 Technology Innovation Award from Frost & Sullivan.Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid market acceptance. Based on its recent analysis of the European biocides market, Frost & Sullivan found that the long-term environmental and economic benefits of using I-Tech’s unique bio-repellent antifouling ingredient, Selektope®, make

Valmet will supply an automation system for Blue Paper's new SRF boiler in Strasbourg, France

Valmet Oyj's trade press release October 31, 2017 at 11:00 a.m. EET Valmet has been selected to supply a Valmet DNA Control System for the new Solid Recovered Fuels (SRF) boiler Blue Paper SAS is building in its site in Strasbourg, France. The order was included in Valmet's third quarter of 2017 orders received. The value of the order will not be disclosed. The delivery is scheduled for early 2018, and process start-up is planned for spring 2018. "We already use Valmet DNA system to control the major part of our Energy and Paper making processes. It will be for sure an advantage for

Invitation to Presentation of SimCorp’s Q3 2017 Interim Report

SimCorp will publish its Q3 2017 interim report to NASDAQ Copenhagen on Tuesday, November 14, 2017 at around 8:00 am (CET). SimCorp’s Executive Management Board will present the report at a conference call the same day at 2:00 pm (CET). Please use any of the following phone numbers to dial in to the conference call:  From Denmark: +45 3271 1658From USA: +1 646 254 3365From other countries: +44(0)20 3427 1908Pin code to access the call: 9169767 At the end of the presentation there will be a Q&A session.    It will also be

Interim Report 1 January – 30 September 2017

Quarterly period July-SeptemberReported revenue, earnings, cash flow and financial ratios relate to continuing operations, and do not include Poolia UK. · Revenue amounted to SEK 180.9 (183.6) million. · Currency effects had an impact of SEK -4.8 million during the quarter. · Operating profit amounted to SEK 7.4 (5.9) million, with an operating margin of 4.1% (3.2%). · Profit before tax was SEK 7.5 (4.8) million. · Profit after tax was SEK 5.3 (3.7) million. · Basic and undiluted earnings per share amounted to SEK 0.31 (0.21). · Cash flow from operations for the

Making Omega-3s Cool: Aker BioMarine Wins Awards for its Work on Health Promotion

The company wins the Innovation Award for its Omega-3 Index Project in Australia and the best annual report award in NorwayOctober 31, 2017, Oslo, Norway: Aker BioMarine just took home the Complementary Medicine Innovation Award, granted by the Complementary Medicines Australia, for its work on omega-3 evangelism in Australia. Last year, Aker BioMarine formed the Omega-3 Index Project  to bring more attention to omega-3 insufficiency, which has become a global health concern. Since the program was extremely well-received in Australia, the company

Fortum-RUSNANO wind investment fund to start implementation of first 50 MW project in Russia

FORTUM CORPORATION INVESTOR NEWS 31 OCTOBER 2017 10.15 EETThe Fortum-RUSNANO wind investment fund is starting implementation of the first50 MW project in Russia. The project is the first of the total 1,000 MW awardedto the fund in the Russian wind auction in June 2017.The first turbine supply agreement for the project (14 turbines, with totalcapacity of approximately 50 MW) is signed with Vestas, who was previouslyselected as a vendor for the main generating equipment supply and services.The wind farm is expected to start production during the first half of 2019.Fortum's long-

Conversion of shares

According to Husqvarna AB´s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in Husqvarna AB. When such a conversion has occurred, the company is obligated by the Act on Trading in Financial Instruments to disclose any such change. In October 2017, at the request of shareholders, 73,200 Class A shares were converted to Class B shares. The total number of votes thereafter amounts to 159,541,051.1. The total number of registered shares in the company amounts to 576,343,778

Kindred Group wins Slots Operator of the Year

Kindred Group has yet another successful year at the EGR Awards 2017 by winning Slots Operator of the Year. The award is a testament to the hard work in adapting product offerings to specific customer preferences, and once again proves Kindred’s exceptional customer focus.Kindred Group (previously Unibet Group) has always prided itself in finding the best quality and product offering to suit specific customer preferences, and was awarded for the hard work at the EGR Awards last week by taking home the Slots Operator of the Year award. Customer centricity continues to be a driving force

Itiviti integrates ETF data from IHS Markit in Delta One solution

London, October 31, 2017 – Itiviti, a global technology provider for the capital markets industry, today announced a strategic alliance with IHS Markit, a world-leader in critical information and analytics solutions, to create a turnkey ETF solution integrating the multi-award winning Tbricks by Itiviti trading platform with SOLA, the comprehensive ETF data service from IHS Markit.The proliferation of ETFs and related products has fueled demand from global regulators and market participants for a fully-integrated trading solution, from composition through to quoting, hedging and risk.

Nomination committee appointed for Serneke Group AB's Annual General Meeting 2018

The members of the nomination committee for Serneke Group AB’s Annual General Meeting in 2018 have now been appointed.The Serneke Group AB Annual General Meeting 2017 has resolved on the principles of how to appoint the nomination committee. According to these principles, the nomination committee shall be appointed following the chairman’s identification of the four largest shareholders, according to voting rights. These shareholders have the right to appoint a representative to the nomination committee. If one or more of the four largest shareholders refrain from their right to appoint a

IMPACT COATINGS INTENDS TO EXECUTE FULLY GUARANTEED RIGHT ISSUE AND DIRECTED SHARE ISSUE

Impact Coatings intends to execute a fully guaranteed rights issue of approximately SEK 84.4 million and a directed share issue of approximately SEK 25 million – in total approximately SEK 109.4 million – to finance the company’s expansion.The Board of Directors of Impact Coatings AB (publ) (“Impact Coatings” or “the Company”) has decided to call an extraordinary general meeting of shareholders on 23 November 2017 (“the EGM”) in order to decide on (i) a rights issue of maximum 8,034,191 new shares (“the Rights Issue”), (ii) an equity issuance of 2,380,953 new shares directed to Accendo

Matti Ruotsala, Deputy CEO will retire from Fortum

FORTUM CORPORATION STOCK EXCHANGE RELEASE 31 OCTOBER AT 10.00 EETOn 31 October, Fortum's Deputy CEO Matti Ruotsala will retire as planned.Ruotsala has been employed by Fortum since 2007 and has held several positionsincluding Executive Vice President of Power Division, Chief Operating Officer,and from 2016 Deputy CEO."In the beginning of my 10 years at Fortum, market prices boomed but soonthereafter the new reality hit when the large scale expansion of renewabletechnologies changed the scene. This led us to renew and restructure Fortum’sbusiness operations and ultimately to

Peptonic Medical enters collaboration agreement with ’1.6 & 2.6 Million Club’

Stockholm October 31, 2017 – Peptonic Medical (publ) (“Peptonic” or “Company”) today announced that it has signed a collaboration and sponsorship agreement with ’1.6 & 2.6 Million Club’. -          Peptonic Medical is a company focusing on women’s health and by this collaboration agreement we want to support research that can lead a better quality of life for women and more effective treatments of women specific diseases, says Johan Inborr, CEO of Peptonic Medcial. Generally, research and development within women’s health has had low priority. We want to change this. -          We are

Promore Pharma Signs Agreement with CRO PCG Clinical Services

STOCKHOLM, 31 October, 2017 -- Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, today announced that an agreement has been entered with PCG Clinical Services AB for the management of the LL-37 Phase IIb trial in patients with hard-to-heal leg ulcers. PCG was selected from several potential partners in a competitive process.Promore Pharma has signed an agreement with CRO PCG Clinical Services regarding the management of Promore Pharma’s LL-37 Phase IIb trial in patients with venous leg ulcers (VLU). The trial is anticipated to recruit 120 patients in Sweden

Aker ASA : Private placement in Aker BP ASA

Reference is made to Aker BP's ("Aker BP") stock exchange announcement today regarding a private placement (the "Private Placement") of 22,376,438 new shares in Aker BP.Aker Capital AS ("Aker"), a wholly-owned subsidiary of Aker ASA, subscribed for and was allocated 8,950,799 new shares in the Private Placement. Aker has entered into a share lending agreement with Nordea Bank AB (publ), filial i Norge ("Nordea"), and Aker BP, whereby Aker has agreed to lend 6,713,491 shares in Aker BP to Nordea to facilitate timely delivery of shares to subscribers in the Private Placement.

Change in number of votes and shares after completion of redemption of preference shares

According to previously disclosed information Balder has completed redemption of 10,000,000 preference shares. Redemption has resulted in a change in the number of shares and votes in Balder. The total number of shares as of 31 October 2017 is 180,000,000 shares, of which 11,229,432 are Class A shares and 168,770,568 are Class B shares. The total number of votes is 28,106,489, of which the Class A shares represent 11,229,432 votes and the Class B shares represent 16,877,057 votes. The information herein constitutes an announcement of a change of the number of shares and votes

Two Instalco companies to carry out installations in new police station in Rinkeby

The Instalco subsidiaries Rörgruppen and Ohmegi Elektro have been entrusted to participate in the construction of a new police station in Rinkeby in northern Stockholm. Rörgruppen’s heating and plumbing installations and Ohmegis electrical work are carried out under a subcontract for NCC, with Familjebostäder as customer. The total order value for Rörgruppen and Ohmegi amounts to approximately SEK 55 million.The assignment comprises the rebuilding of an existing residential property and an extension with a total area of approximately 14,500 square meters. The property will to a large extent

NeuroVive signs collaboration agreement with University of Florida for TBI biomarker development

Lund, Sweden, 31 October 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company has signed a collaboration agreement with Kevin K.W. Wang, Ph.D., of the University of Florida to conduct biomarker research for NeuroVive’s traumatic brain injury (TBI) program. The research is aimed at developing alternative endpoints for the company’s clinical TBI program by analysing patient samples from the previously completed CHIC study.The research will evaluate the use of biofluid-based biomarkers in TBI drug development, which is increasingly

Orexo issues bonds of SEK 325 million and confirms fulfilment of condition under notice of early redemption

Uppsala, Sweden – October 31, 2017 – Orexo AB (publ.) (the “Company”) has issued a four-year senior unsecured bond loan in an amount of SEK 325 million, within a framework amount of SEK 500 million, due in November 2021. The bond loan has a floating interest rate of STIBOR 3m +4.50 per cent per year (quarterly payments in arrears). The net proceeds from the issue will mainly be used towards prepayment of the Company’s existing outstanding bond loan and for general corporate purposes. The issue date for the new bonds is expected to be 13 November 2017. The Company intends to list the new

NextCell Pharma updates on its situation in its fourth quarter report

NextCell Pharma AB ("NEXTCL", "NextCell") today releases its Q4 / year-end report (June 1st - August 31st  / September 1st - August 31st). This is the first quarterly report since the listing on Aktietorget. The company reports a loss of SEK -4,757,996 in its fourth quarter and a loss of SEK -13,245,206 for the entire financial year. The remaining cash at August 31st was approximately 16 MSEK.The perhaps most important event during the fourth quarter was the listing on Aktietorget on July 13th and the associated listing issue, which was subscribed to approximately 18 MSEK, corresponding to

Phase Holographic Imaging initiates CFO succession

Arne Bojesson has since PHI’s IPO in early 2014 been the CFO of PHI. During this time, he has successfully established well-functioning accounting routines, capable of handling PHI’s development. After nearly four years at PHI, Arne Bojesson, age 66, has decided to end his assignment. The company now initiates the recruitment of a successor to Bojesson, who will remain CFO until his position has been securely filled. In conjunction with leaving the Company, Bojesson has divested his holdings of 19 480 shares (0.17%) in PHI. “It has been a pleasure to work with Arne who with his long

AKER BP: NOK 4.1Bn PRIVATE PLACEMENT FULLY SUBSCRIBED

DISCLAIMER: This information is subject to disclosure under the Norwegian Securities Trading Act, Section 5-12. This announcement is not and does not form a part of any offer for sale of any securities, and is for release, publication or distribution, directly or indirectly, in the United States, or any other jurisdiction in which such distribution would be unlawful or would require registration  or other measures. Securities may not be sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S.

AKER BP: DIVIDEND RIGHTS IN CONTEMPLATED PRIVATE PLACEMENT

Reference is made to the announcement by Aker BP ASA (the “Company”) yesterday, 30 October 2017, at 16:38 CET, regarding a contemplated private placement (the “Private Placement”) of new shares in the Company. Investors who participate in the Private Placement are informed that the shares offered in the Private Placement will be delivered inclusive of the right to receive the cash dividend as announced by the Company yesterday, 30 October 2017, at 07:01 CET, of USD 0.185 per share, assuming that settlement of the Private Placement, by delivery and payment of shares, takes place on a

There are no items matching the current filter
There are no more items matching the current filter
Back to top